Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2002ScienceOpen Access

Activation of Central Melanocortin Pathways by Fenfluramine

View Full Paper
Ask AI
Bookmark
Share

Authors

LHLora K. HeislerUniversity of AberdeenMCMichael A. CowleyDiscovery InstituteLTLaurence H. TecottScripps Research Institute

Discussion

Loading...

Member takes

Implication

Experimental study reveals that central melanocortin pathway activation mediates fenfluramine-induced appetite suppression in rodents, highlighting a selective target for obesity treatments.

Key Points

  • To identify the neural circuits in the central nervous system responsible for the appetite-suppressing actions of d-fenfluramine.
  • Conducted functional neuroanatomy and electrophysiological recordings in rodent models.
  • Evaluated feeding behavior and anorexic responses following d-fenfluramine exposure.
  • Demonstrated that d-fenfluramine-induced anorexia requires the activation of central nervous system melanocortin pathways.
  • Identified downstream melanocortin signaling as a mechanistic target capable of mediating selective anti-obesity effects without the cardiac risks of d-fenfluramine.

Cite This Study

Heisler et al. (2002) studied this question.

synapsesocial.com/papers/6a705ac52163a0a01bc4936dhttps://doi.org/10.1126/science.1072327
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Central Melanocortin System Can Directly Regulate Serum Insulin Levels*2000 · 281 citations
  2. 2Clinical Studies with Dexfenfluramine: From Past to Future1995 · 43 citations